Venture CapitalData & Analysis

This article is part one of a series on VC perspectives and how VCs are responding and supporting their portfolios in response to the realities of COVID-19. If you would like to provide commentary, please contact us here. Breezing past trade disputes and political volatility, yield-curves and domestic energy conflicts, venture capital in Canada is

On December 19, 2019, Alberta-based Decisive Farming announced it had been acquired by Vancouver-headquartered TELUS. The terms of the deal were not disclosed. CVCA members, McRock Capital, were early investors in the company and the acquisition represents a successful exit for the fund. According to AgFunderNews, Decisive Farming combines precision agronomics, crop marketing, and information

This article is part two of a two-part series providing insights from leading women in Canadian private capital in celebration of International Women’s Day. The CVCA will be publishing its 2019 year-end report next week and the preliminary numbers show Canadian venture capital heading towards another record year for investment and private equity continuing its

Photo: mnubo Co-founders (left to right): Frédéric Bastien, Jean-Charles Beaudin, Jean-Christophe Cimino, Aditya Pendyala On July 12, Montreal-based mnubo Inc. announced it had been acquired by Massachusetts-based Aspen Technologies for CAD $102M. CVCA members White Star Capital and McRock Capital had been early investors in mnubo and the acquisition represents a successful exit for the funds.

In a CVCA Central first, we spoke with Lumira Ventures to go behind the scene of three of their recent deals. On April 8, Michigan-based medical device company HistoSonics, announced it had raised USD $54 million in a Series C financing including participation from Lumira Ventures. HistoSonics is a venture-backed medical device company developing a

On April 18, Toronto-based VC fund, iGan Partners, announced it had raised CAD $100M for its first fund, iGan Fund I; surpassing its initial goal of CAD $50M. The fund is focused on the health technology sector which includes digital health, medical devices, healthcare IT and AI. The fund will also provide diversified exposure to

Photo (left to right): inovia capital General Partners, Patrick Pichette, Dennis Kavelman and Chris Arsenault On February 19, Montreal-based inovia capital announced it had raised a fourth USD $200M early-stage fund and a new USD $400M growth-stage fund. The firm also announced that it is expanding to core markets in Canada and Silicon Valley and opened a